pubrio
Novo Nordisk logo

Novo Nordisk

Public
+3
novonordisk.com
제약 제조64,800+ employeesFounded 1923🇩🇰 덴마크

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 69,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

설립
1923
직원
64,800+
산업
제약 제조
회사 유형
Public Company
주식
nasdaq: NVO
본사
🇩🇰Bagsværd (+18)
전문 분야
제약생명 공학의료제약 제조

확장 인텔리전스

NEW · Pubrio 단독

Novo Nordisk의 시장 확장을 추적하고 있습니다

글로벌 확장

실시간
단계
탐색 중투자 중진입 중운영 중

활동 펄스

최근 90일간 시그널 315건.

최근 90일
채용
95↑ +64%
채용
마케팅 및 PR
207↑ +11%
광고
제품 및 기술
12↑ +100%
제품 출시
+2개 카테고리 더잠김
5개 중 3개 표시
알아두면 좋은 정보

Novo Nordisk 관련 자주 묻는 질문

Novo Nordisk의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 69,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

오늘 바로 여정을 시작하세요

플랫폼부터 시작해도, 대화부터 시작해도 좋습니다

직접 Pubrio 를 사용하거나, 연구·리드 생성·데이터 통합을 저희 팀에 맡겨 보세요.

팀과 상담하기
Start Journey Image
pubrio

Pubrio는 50개 이상의 로컬 소스에서 비즈니스·인물·의도 데이터를 통합해 하나의 글로벌 그래프로 제공, 시장 전체 가시성을 확보하게 합니다.

© 2026 Pubrio. 모든 권리 보유.